These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


228 related items for PubMed ID: 350128

  • 1. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH, Cramer JA, Williamson PD, Novelly RA.
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [Abstract] [Full Text] [Related]

  • 2. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W, Schulz HU, Gugler R.
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [Abstract] [Full Text] [Related]

  • 3. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.
    Davis R, Peters DH, McTavish D.
    Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905
    [Abstract] [Full Text] [Related]

  • 4. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.
    Lecchini S, Gatti G, De Bernardi M, Caravaggi M, Frigo GM, Calzetti S, Visintini D.
    Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060
    [No Abstract] [Full Text] [Related]

  • 5. Valproate sodium in epilepsy. A clinical trial including monitoring of drug levels.
    Mehrotra TN, Aneja GK, Arora V, Goel S, Singh VS.
    J Assoc Physicians India; 1990 Apr; 38(4):277-9. PubMed ID: 2118134
    [Abstract] [Full Text] [Related]

  • 6. Valproic acid: in vitro plasma protein binding and interaction with phenytoin.
    Cramer JA, Mattson RH.
    Ther Drug Monit; 1979 Apr; 1(1):105-16. PubMed ID: 121944
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD, Sansom LN.
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [Abstract] [Full Text] [Related]

  • 11. Binding of drugs to human serum albumin. XIV. The theoretical basis for the interaction between phenytoin and valproate.
    Kober A, Olsson Y, Sjöholm I.
    Mol Pharmacol; 1980 Sep; 18(2):237-42. PubMed ID: 6775182
    [No Abstract] [Full Text] [Related]

  • 12. Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
    Patsalos PN, Lascelles PT.
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):570-4. PubMed ID: 20483
    [Abstract] [Full Text] [Related]

  • 13. [Clinical--pharmacological aspects of treatment with sodium di-n-propylacetate].
    Wulff K, Flachs H, Würtz-Jørgensen A, Gram L.
    Ugeskr Laeger; 1977 May 02; 139(18):1059-64. PubMed ID: 324057
    [No Abstract] [Full Text] [Related]

  • 14. In vivo determination of valproate binding constants during sole and multi-drug therapy.
    Scheyer RD, Cramer JA, Toftness BR, Hochholzer JM, Mattson RH.
    Ther Drug Monit; 1990 Mar 02; 12(2):117-23. PubMed ID: 2107606
    [Abstract] [Full Text] [Related]

  • 15. [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine].
    Loiseau P, Cohadon S, Jogeix M, Legroux M, Dartigues JF.
    Rev Neurol (Paris); 1984 Mar 02; 140(6-7):434-7. PubMed ID: 6431586
    [Abstract] [Full Text] [Related]

  • 16. Interaction between phenytoin and valproate.
    Sansom LN, Beran RC, Schapel GJ.
    Med J Aust; 1980 Aug 23; 2(4):212. PubMed ID: 6776391
    [Abstract] [Full Text] [Related]

  • 17. [Problems in serum-level determination during valproic acid therapy].
    Schäfer H, Reith H, Jacobs R, Gabriel KH.
    Arzneimittelforschung; 1977 Aug 23; 27(6):1215-21. PubMed ID: 332187
    [Abstract] [Full Text] [Related]

  • 18. Valproate may lower serum-phenytoin.
    Bardy A, Hari R, Lehtovaara R, Majuri H.
    Lancet; 1976 Dec 11; 2(7998):1297-8. PubMed ID: 63764
    [No Abstract] [Full Text] [Related]

  • 19. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin.
    Miles MV, Snead OC, Thorn MD.
    Clin Pharm; 1988 Sep 11; 7(9):688-93. PubMed ID: 3149223
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy.
    Rastogi P, Mehrotra TN, Agarwala RK, Singh VS.
    J Assoc Physicians India; 1991 Aug 11; 39(8):606-8. PubMed ID: 1814875
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.